The U.S. is grappling with how to rein in high drug prices. Unfortunately, most of the proposed solutions work better on a bumper sticker than in reality. The debate, however, tends to ignore a key player -- the prescribing doctor -- who could have a central role in a more sustainable approach to better value in drug pricing.
One year ago, with the flick of his thumb, Sen. John McCain (R-Ariz.) foiled the Republican Party’s quest to undo the Affordable Care Act and fulfill a seven-year promise to remake the health-care system.
Red-state Democrats are signaling some solidarity with the rest of the caucus on at least one policy issue flaring in the fight over Brett Kavanaugh’s Supreme Court nomination. Lawmakers including Sens. Joe Manchin (WV), Joe Donnelly (IN), and Heidi Heitkamp (ND) — all Democrats representing states that Donald Trump won by a wide margin in 2016 — are among those backing a new Senate resolution aimed at defending the constitutionality of the Affordable Care Act.
Anthem’s decision to exit some individual markets under the Affordable Care Act in favor of growing its Medicare business helped boost profits in the health insurer’s second quarter.
From credit card debt to saving for retirement and paying for children’s education expenses, stress over finances is taking a major toll on employees — and it’s also taking a major toll on the workplace as a result.
The CEO of health insurer Cigna, David Cordani, says the problem with America's healthcare system is that most of the money is being spent on intervention after people already are sick. Cordani believes we need to spend more money and resources keeping people healthy in the first place.